2017 Annual Meeting of the Association for Research in Vision and Ophthalmology

Anti-VEGF in the Treatment of Retinal Disease:Bringing Long-term, Real-world Outcomes into Focus

By PETER J. KERTES, MD, CM, FRCSC

The Role of Nutritional Supplements in the Management of Age-related Macular Degeneration

By EFREM D. MANDELCORN, MD, FRCSC

ERRATUM

2016 Annual Meeting of the Association for Research in Vision and Ophthalmology

Anti-vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration,
Diabetic Macular Edema, and Diabetic Retinopathy: Outcomes of Recent Long-term Clinical Trials

By DAVID ASSAAD, MD, FRCSC 

American Academy of Ophthalmology Annual Meeting

Next Frontiers in the Management of Neovascular Age-related Macular Degeneration
Reported and discussed by: JASON NOBLE, MD, FRCSC

 

Analysis of the recent DCRC.net trial

Evaluating the Comparative Efficacy and Safety of Anti-VEGF Agents in Treating DME:
A Canadian Perspective on the Protocol T Trial

Reported and discussed by: DAVID ASSAAD, MD, FRCSC

 

2015 Canadian Retina Society Meeting

Management of Macular Holes in 2015
Reported and discussed by: DAVID R. CHOW, MD, FRCSC, MICHAEL KAPUSTA, MD, FRCSC,
and NETAN CHOUDHRY, MD, FRCSC, DABO

 

ASRS & AAO

Anti-VEGF in the Treatment of Retinal Disease: A Decade of Clinical Experience
Reported and discussed by: WAI-CHING LAM, MD, FRCSC and EMMANOUIL MAVRIKAKIS, MD, PhD

 

ARVO 2014

Contemporary Management of Retinal Disease: Focus on Individualized Treatment Approaches
Reported and discussed by: NUPURA K. BAKSHI, MD, FRCSC

 

ASRS

Management of Retinal Disease in the Era of Anti-VEGF Therapies
Reported and discussed by EFREM D. MANDELCORN, MD, FRCSC

 

Will Individualized Therapy Become Standard of Care for Age-related Macular Degeneration?
Reported and discussed by: PETER J. KERTES, MD, CM, FRCSC, and THOMAS G. SHEIDOW, MD, FRCSC, MMath

 

75th COS Annual Meeting

Canadian Ophthalmological Society (COS) Diabetic Retinopathy Guidelines: Implications for Daily Clinical Practice
Reported and discussed by: NUPURA BAKSHI, MD, FRCSC

 

2012 ARVO

New Insights into the Treatment of Wet Age-related Macular Degeneration in the Era of Anti-VEGF Therapies
Reported and discussed by: DAVID T. WONG, MD, FRCSC, and WAI CHING LAM, MD, FRCSC

 

Dry Eye: A Comprehensive Approach to Diagnosis and Management
Reported and discussed by: MATTHEW C. BUJAK, MD, FRCSC

 

Benefits and Risks of Inhibiting Vascular Endothelial Growth Factor (VEGF) at the Ocular Level:
From Bench to Bedside

Reported and discussed by: Subodh Verma, MD, PhD, FRCSC, FAHA; Alan R. Berger, BSc, MD, FRCSC; David R. Chow, MD, FRCSC

 

WOC and COS

Retina-related Highlights from WOC and COS
Reported and discussed by: WAI CHING LAM, MD, FRCSC, and PETER J. KERTES, MD, CM, FRCSC 
Originally presented by: L. Aiello, MD; G. Lang, MD; P. Mitchell, MD; E. Tourville, MD; D. Wong, MD; B. Leonard, MD; G. Katz, MD; P. Kertes , MD; J . Kent , MD; T. Sheidow, MD; D. Chow, MD; P. Hooper, MD; E. Chew, MD